Roberto Cauda

21.1k citations
437 papers · 16.9k · 3 hit papers · h-index 63

Impact in

Papers in

    • HIV/AIDS drug development and treatment 101
    • HIV/AIDS Research and Interventions 39
    • COVID-19 Clinical Research Studies 27
    • SARS-CoV-2 and COVID-19 Research 24
    • HIV Research and Treatment 84

Roberto Cauda

425 papers receiving 16.3k citations

Roberto Cauda's Hit Papers

Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses 2022 · 289 citations
2890+7+15Years since publication2505007501000

Peers

Roberto Cauda
Comparison fields: 5 of 184
  • Applied Microbiology and Biotechnology 1.3k
  • Molecular Medicine 3.3k
  • Virology 1.9k
  • Infectious Diseases 6.8k
  • Clinical Biochemistry 1.2k
Replace Ann Sarah Walker with:
Ann Sarah Walker United Kingdom
Marilyn M. Wagener United States
Robert A. Salata United States
Gregory J. Moran United States
Shan‐Chwen Chang Taiwan
Pierluigi Viale Italy
David A. Talan United States
Lee H. Harrison United States
Nicola Petrosillo Italy
George L. Drusano United States
Roberto Cauda relative to Ann Sarah Walker United Kingdom Ann Sarah Walker's profile →
Citations per field
00.5×2×2.6×
Ann Sarah Walker · 1×
Citations per year

Countries citing papers authored by Roberto Cauda

Since Specialization
Citations

This map shows the geographic impact of Roberto Cauda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Cauda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Cauda more than expected).

Fields of papers citing papers by Roberto Cauda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberto Cauda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Cauda. The network helps show where Roberto Cauda may publish in the future.

Co-authors

The 25 scholars most cited alongside Roberto Cauda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Roberto Cauda Line = papers co-authored together Roberto Cauda links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 437 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Effects of chloroquine on viral infections: an old drug against today's diseases
Hit paper breakdown →
20031017
2
Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy
Hit paper breakdown →
2012863
3 2006452
4 2015451
5 1996424
6 2007382
7 2007349
8 2018323
9 2007297
10
Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses
Hit paper breakdown →
2022289
11 2006234
12 2021229
13 2014222
14 2011210
15 2020190
16 1999178
17 2012175
18 2010175
19 2006172
20 2002171

About Roberto Cauda

Roberto Cauda is a scholar working on Infectious Diseases, Virology, Epidemiology, Emergency Medicine and Molecular Medicine, having authored 437 papers that have together received 16.9k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (101 papers), HIV Research and Treatment (84 papers), Pneumocystis jirovecii pneumonia detection and treatment (40 papers), HIV/AIDS Research and Interventions (39 papers), HIV-related health complications and treatments (33 papers), Antibiotic Resistance in Bacteria (29 papers), COVID-19 Clinical Research Studies (27 papers) and SARS-CoV-2 and COVID-19 Research (24 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (1.3k citations), Molecular Medicine (3.3k citations), Virology (1.9k citations), Infectious Diseases (6.8k citations) and Clinical Biochemistry (1.2k citations). Roberto Cauda has collaborated with scholars based in Italy, United States and Japan. Frequent co-authors include Mario Tumbarello, Antonio Cassone, Evelina Tacconelli, Andrea Savarino, Enrico Maria Trecarichi, Teresa Spanu, Andrea De Luca, Giovanni Fadda, Luigi Ortona and Maurizio Sanguinetti. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, JAIDS Journal of Acquired Immune Deficiency Syndromes, Journal of Infection, Antiviral Therapy and Clinical Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact